Duration of methadone and buprenorphine-naloxone treatment
Kleinman RA, Kurdyak P. JAMA Netw Open. 2025; 8(7):e2518389.
Publications
COVID-19 vaccine uptake in a retrospective population-based cohort of people living with and without HIV in Ontario, Canada
Freitas C, Cooper CL, Kroch AE, Moineddin R, Arbess G, Benoit AC, Buchan SA, Chambers C, Habanyama M, Kendall CE, Kwong JC, Mbuagbaw L, McCullagh J, Moqueet N, Nambiar D, Rueda S, Tran V, Walmsley S, Burchell AN; CHESS Study Team. Vaccine. 2025; 61:127422. Epub 2025 Jul 1.
Abortion ratios after first-trimester exposure to teratogenic medication in people with disabilities
Camden A, Sharpe I, Lu H, Brown HK. Epidemiology. 2025; Mar 24 [Epub ahead of print].
Retention in opioid agonist therapy among First Nations people in Ontario, Canada: a retrospective cohort study
Holton A, Hamzat B, McCormack D, Bragg S, deGonzague B, Mecredy G, Campbell T, Antoniou T, McGregor L, Bertram J, Gomes T. JAMA Netw Open. 2025; 8(6):e2518452.
Changing trends in safer opioid supply uptake, dose and hydromorphone volume in Ontario: a population-based cross-sectional study
Xu F, Wang T, Kolla G, Campbell T, Watts T, Ledlie S, Koncz D, Tadrous M, Gomes T. Int J Drug Policy. 2025; 143:104905. Epub 2025 Jun 28.
Glucagon-like peptide 1 receptor agonists and the risk of emergency department visits and hospitalization in patients with chronic kidney disease
Yau K, Ray JG, Jeyakumar N, Luo B, Abdullah S, McArthur E, Dixon SN, Wing S, Clemens KK, Castrillon-Ramirez F, Udell JA, Meraz-Munoz A, Young A, Harel Z, Perl J, Sridhar VS, Ni H, Yi TW, Leiter LA, Garg AX, Cherney DZI, Wald R. Diabetes Care. 2025; dc242811. Epub 2025 Jun 26.
Association between statin use and post-ischemic stroke epilepsy among older adults: a nested case-control study
Couper RG, Antaya TC, Carter B, Shariff SZ, Sposato LA, Muanda FT, Burneo JG. Epilepsy Res. 2025; 217:107617. Epub 2025 Jun 19.
The rise and fall of raloxifene use for osteoporosis, 1999-2022
Shogry FF, Hayes KN, Kim S, Burden AM, Tadrous M, Aggarwal S, Cadarette SM. Osteoporos Int. 2025; Jun 11 [Epub ahead of prin]t.
Risk of Guillain-Barré syndrome after COVID-19 vaccination or SARS-CoV-2 infection: a multinational self-controlled case series study
Nasreen S, Jiang Y, Lu H, Lee A, Cutland CL, Gentile A, Giglio N, Macartney K, Deng L, Liu B, Sonneveld N, Bellamy K, Clothier HJ, Sepulveda Kattan G, Naus M, Naveed Z, Janjua NZ, Nguyen L, Hviid A, Poukka E, Perälä J, Leino T, Chandra LA, Thobari JA, Park BJ, Choi NK, Jeong NY, Madhi SA, Villalobos F, Solórzano M, Bissacco CA, Carreras-Martínez JJ, Correcher-Martínez E, Urchueguía-Fornes A, Roy D, Yeomans A, Aurelius T, Morton K, Di Mauro G, Sturkenboom MC, Sejvar JJ, Top KA, Batty K, Ghebreab L, Griffin JB, Petousis-Harris H, Buttery J, Black S, Kwong JC. Vaccine. 2025 May 28;60:127291. [Epub ahead of print].
Association of direct oral anticoagulant-proton pump inhibitor co-therapy with adverse outcomes: a population-based cohort study
Wang M, Paterson JM, Nguyen F, Siegal DM, Targownik L, Holbrook AM. Ann Pharmacother. 2025; May 28 [Epub ahead of print].